Terms: = Endocrine gland cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
7 results:
1. Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous Ovarian cancer.
Lee SW; Lee HY; Kang SW; Kim MJ; Lee YJ; Sung CO; Kim YM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502561
[TBL] [Abstract] [Full Text] [Related]
2. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
[TBL] [Abstract] [Full Text] [Related]
3. Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography.
Gong RX; Gong YP; Yang J; Wei T; Li-Ling J; Zhu JQ
Genet Mol Res; 2013 Oct; 12(4):4990-7. PubMed ID: 24301760
[TBL] [Abstract] [Full Text] [Related]
4. Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.
Pulcrano M; Boukheris H; Talbot M; Caillou B; Dupuy C; Virion A; De Vathaire F; Schlumberger M
Thyroid; 2007 Jul; 17(7):639-46. PubMed ID: 17696834
[TBL] [Abstract] [Full Text] [Related]
5. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
Beck SD; Cheng L; Bihrle R; Donohue JP; Foster RS
J Urol; 2007 Mar; 177(3):944-6. PubMed ID: 17296383
[TBL] [Abstract] [Full Text] [Related]
6. Gains and losses of CD8, cd20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
[TBL] [Abstract] [Full Text] [Related]
7. Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
Schaap J; Eustatia-Rutten CF; Stokkel M; Links TP; Diamant M; van der Velde EA; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2002 Jul; 57(1):117-24. PubMed ID: 12100079
[TBL] [Abstract] [Full Text] [Related]
